This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandori, M. W.
Right arrow Articles by Guatelli, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandori, M. W.
Right arrow Articles by Guatelli, J. C.

 Previous Article  |  Next Article 

J. Virol., 07 1996, 4283-4290, Vol 70, No. 7
Copyright © 1996, American Society for Microbiology

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

MW Pandori, NJ Fitch, HM Craig, DD Richman, CA Spina and JC Guatelli
Department of Medicine, University of California San Diego School of Medicine, California 92093-0619, USA.

Type 1 human immunodeficiency viruses encoding mutated nef reading frames are 10- to 30-fold less infectious than are isogenic viruses in which the nef gene is intact. This defect in infectivity causes nef- negative viruses to grow at an attenuated rate in vitro. To investigate the mechanism of Nef-mediated enhancement of viral growth rate and infectivity, a complementation analysis of nef mutant viruses was performed. To provide Nef in trans upon viral infection, a CEM derivative cell line (designated CLN) that expresses Nef under the control of the viral long terminal repeat was constructed. When nef- negative virus was grown in CLN cells, its growth rate was restored to wild-type levels. However, the output of nef-negative virus during the first 72 h after infection of CLN cells was not restored, suggesting that provision of Nef within the newly infected cell does not enhance the productivity of a nef-negative provirus. The genetically nef- negative virions produced by the CLN cells, however, were restored to wild-type levels of infectivity as measured in a syncytium formation assay in which CD4-expressing HeLa cells were targets. These trans- complemented, genetically nef-negative virions yielded wild-type levels of viral output following a single cycle of replication in primary CD4 T cells as well as in parental CEM cells. To define the determinants for producer cell modification of virions by Nef, the role of myristoylation was investigated. Virus that encodes a myristoylation- negative nef was as impaired in infectivity as was virus encoding a deleted nef gene. Because myristoylation is required for both membrane association of Nef and optimal viral infectivity, the possibility that Nef protein is included in the virion was investigated. Wild-type virions were purified by filtration and exclusion chromatography. A Western blot (immunoblot) of the eluate fractions revealed a correlation between peak Nef signal and peak levels of p24 antigen. Although virion-associated Nef was detected in part as the 27-kDa full- length protein, the majority of immunoreactive protein was detected as a 20-kDa isoform. nef-negative virus lacked both 27- and 20-kDa immunoreactive species. Production of wild-type virions in the presence of a specific inhibitor of the human immunodeficiency virus type 1 protease resulted in virions which contained only 27-kDa full-length Nef protein. These data indicate that Nef is a virion protein which is processed by the viral protease into a 20-kDa isoform within the virion particle.


This article has been cited by other articles:

  • Pizzato, M., Popova, E., Gottlinger, H. G. (2008). Nef Can Enhance the Infectivity of Receptor-Pseudotyped Human Immunodeficiency Virus Type 1 Particles. J. Virol. 82: 10811-10819 [Abstract] [Full Text]  
  • Sacha, J. B., Chung, C., Reed, J., Jonas, A. K., Bean, A. T., Spencer, S. P., Lee, W., Vojnov, L., Rudersdorf, R., Friedrich, T. C., Wilson, N. A., Lifson, J. D., Watkins, D. I. (2007). Pol-Specific CD8+ T Cells Recognize Simian Immunodeficiency Virus-Infected Cells Prior to Nef-Mediated Major Histocompatibility Complex Class I Downregulation. J. Virol. 81: 11703-11712 [Abstract] [Full Text]  
  • Pizzato, M., Helander, A., Popova, E., Calistri, A., Zamborlini, A., Palu, G., Gottlinger, H. G. (2007). Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc. Natl. Acad. Sci. USA 104: 6812-6817 [Abstract] [Full Text]  
  • Qi, M., Aiken, C. (2007). Selective Restriction of Nef-Defective Human Immunodeficiency Virus Type 1 by a Proteasome-Dependent Mechanism. J. Virol. 81: 1534-1536 [Abstract] [Full Text]  
  • Quaranta, M. G., Mattioli, B., Giordani, L., Viora, M. (2006). The immunoregulatory effects of HIV-1 Nef on dendritic cells and the pathogenesis of AIDS. FASEB J. 20: 2198-2208 [Abstract] [Full Text]  
  • Vincent, P., Priceputu, E., Kay, D., Saksela, K., Jolicoeur, P., Hanna, Z. (2006). Activation of p21-activated Kinase 2 and Its Association with Nef Are Conserved in Murine Cells but Are Not Sufficient to Induce an AIDS-like Disease in CD4C/HIV Transgenic Mice. J. Biol. Chem. 281: 6940-6954 [Abstract] [Full Text]  
  • Rue, S. M., Roos, J. W., Tarwater, P. M., Clements, J. E., Barber, S. A. (2005). Phosphorylation and Proteolytic Cleavage of Gag Proteins in Budded Simian Immunodeficiency Virus. J. Virol. 79: 2484-2492 [Abstract] [Full Text]  
  • Keppler, O. T., Allespach, I., Schuller, L., Fenard, D., Greene, W. C., Fackler, O. T. (2005). Rodent Cells Support Key Functions of the Human Immunodeficiency Virus Type 1 Pathogenicity Factor Nef. J. Virol. 79: 1655-1665 [Abstract] [Full Text]  
  • Hill, B. T., Skowronski, J. (2005). Human N-Myristoyltransferases Form Stable Complexes with Lentiviral Nef and Other Viral and Cellular Substrate Proteins. J. Virol. 79: 1133-1141 [Abstract] [Full Text]  
  • Fortin, J.-F., Barat, C., Beausejour, Y., Barbeau, B., Tremblay, M. J. (2004). Hyper-responsiveness to Stimulation of Human Immunodeficiency Virus-infected CD4+ T Cells Requires Nef and Tat Virus Gene Products and Results from Higher NFAT, NF-{kappa}B, and AP-1 Induction. J. Biol. Chem. 279: 39520-39531 [Abstract] [Full Text]  
  • Kirchhoff, F., Schindler, M., Bailer, N., Renkema, G. H., Saksela, K., Knoop, V., Muller-Trutwin, M. C., Santiago, M. L., Bibollet-Ruche, F., Dittmar, M. T., Heeney, J. L., Hahn, B. H., Munch, J. (2004). Nef Proteins from Simian Immunodeficiency Virus-Infected Chimpanzees Interact with p21-Activated Kinase 2 and Modulate Cell Surface Expression of Various Human Receptors. J. Virol. 78: 6864-6874 [Abstract] [Full Text]  
  • Lundquist, C. A., Zhou, J., Aiken, C. (2004). Nef Stimulates Human Immunodeficiency Virus Type 1 Replication in Primary T Cells by Enhancing Virion-Associated gp120 Levels: Coreceptor-Dependent Requirement for Nef in Viral Replication. J. Virol. 78: 6287-6296 [Abstract] [Full Text]  
  • Schiavoni, I., Trapp, S., Santarcangelo, A. C., Piacentini, V., Pugliese, K., Baur, A., Federico, M. (2004). HIV-1 Nef Enhances Both Membrane Expression and Virion Incorporation of Env Products: A MODEL FOR THE NEF-DEPENDENT INCREASE OF HIV-1 INFECTIVITY. J. Biol. Chem. 279: 22996-23006 [Abstract] [Full Text]  
  • Costa, L. J., Zheng, Y.-H., Sabotic, J., Mak, J., Fackler, O. T., Peterlin, B. M. (2004). Nef Binds p6* in GagPol during Replication of Human Immunodeficiency Virus Type 1. J. Virol. 78: 5311-5323 [Abstract] [Full Text]  
  • Alexander, M., Bor, Y.-c., Ravichandran, K. S., Hammarskjold, M.-L., Rekosh, D. (2004). Human Immunodeficiency Virus Type 1 Nef Associates with Lipid Rafts To Downmodulate Cell Surface CD4 and Class I Major Histocompatibility Complex Expression and To Increase Viral Infectivity. J. Virol. 78: 1685-1696 [Abstract] [Full Text]  
  • Khan, M., Jin, L., Huang, M. B., Miles, L., Bond, V. C., Powell, M. D. (2004). Chimeric Human Immunodeficiency Virus Type 1 (HIV-1) Virions Containing HIV-2 or Simian Immunodeficiency Virus Nef Are Resistant to Cyclosporine Treatment. J. Virol. 78: 1843-1850 [Abstract] [Full Text]  
  • QUARANTA, M. G., MATTIOLI, B., SPADARO, F., STRAFACE, E., GIORDANI, L., RAMONI, C., MALORNI, W., VIORA, M. (2003). HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 17: 2025-2036 [Abstract] [Full Text]  
  • Wu, Y., Marsh, J. W. (2003). Early Transcription from Nonintegrated DNA in Human Immunodeficiency Virus Infection. J. Virol. 77: 10376-10382 [Abstract] [Full Text]  
  • Tobiume, M., Lineberger, J. E., Lundquist, C. A., Miller, M. D., Aiken, C. (2003). Nef Does Not Affect the Efficiency of Human Immunodeficiency Virus Type 1 Fusion with Target Cells. J. Virol. 77: 10645-10650 [Abstract] [Full Text]  
  • Forshey, B. M., Aiken, C. (2003). Disassembly of Human Immunodeficiency Virus Type 1 Cores In Vitro Reveals Association of Nef with the Subviral Ribonucleoprotein Complex. J. Virol. 77: 4409-4414 [Abstract] [Full Text]  
  • Janvier, K., Craig, H., Hitchin, D., Madrid, R., Sol-Foulon, N., Renault, L., Cherfils, J., Cassel, D., Benichou, S., Guatelli, J. (2003). HIV-1 Nef Stabilizes the Association of Adaptor Protein Complexes with Membranes. J. Biol. Chem. 278: 8725-8732 [Abstract] [Full Text]  
  • Stoddart, C. A., Geleziunas, R., Ferrell, S., Linquist-Stepps, V., Moreno, M. E., Bare, C., Xu, W., Yonemoto, W., Bresnahan, P. A., McCune, J. M., Greene, W. C. (2003). Human Immunodeficiency Virus Type 1 Nef-Mediated Downregulation of CD4 Correlates with Nef Enhancement of Viral Pathogenesis. J. Virol. 77: 2124-2133 [Abstract] [Full Text]  
  • Papkalla, A., Munch, J., Otto, C., Kirchhoff, F. (2002). Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity and Replication Independently of Viral Coreceptor Tropism. J. Virol. 76: 8455-8459 [Abstract] [Full Text]  
  • Dorfman, T., Popova, E., Pizzato, M., Gottlinger, H. G. (2002). Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity in the Absence of Matrix. J. Virol. 76: 6857-6862 [Abstract] [Full Text]  
  • Lundquist, C. A., Tobiume, M., Zhou, J., Unutmaz, D., Aiken, C. (2002). Nef-Mediated Downregulation of CD4 Enhances Human Immunodeficiency Virus Type 1 Replication in Primary T Lymphocytes. J. Virol. 76: 4625-4633 [Abstract] [Full Text]  
  • Khan, M., Garcia-Barrio, M., Powell, M. D. (2001). Restoration of Wild-Type Infectivity to Human Immunodeficiency Virus Type 1 Strains Lacking nef by Intravirion Reverse Transcription. J. Virol. 75: 12081-12087 [Abstract] [Full Text]  
  • Jenkins, Y., Sanchez, P. V., Meyer, B. E., Malim, M. H. (2001). Nuclear Export of Human Immunodeficiency Virus Type 1 Vpr Is Not Required for Virion Packaging. J. Virol. 75: 8348-8352 [Abstract] [Full Text]  
  • Wu, Y., Marsh, J. W. (2001). Selective Transcription and Modulation of Resting T Cell Activity by Preintegrated HIV DNA. Science 293: 1503-1506 [Abstract] [Full Text]  
  • Fackler, O. T., d'Aloja, P., Baur, A. S., Federico, M., Peterlin, B. M. (2001). Nef from Human Immunodeficiency Virus Type 1F12 Inhibits Viral Production and Infectivity. J. Virol. 75: 6601-6608 [Abstract] [Full Text]  
  • Zhou, J., Aiken, C. (2001). Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity Resulting from Intervirion Fusion: Evidence Supporting a Role for Nef at the Virion Envelope. J. Virol. 75: 5851-5859 [Abstract] [Full Text]  
  • Chazal, N., Singer, G., Aiken, C., Hammarskjöld, M.-L., Rekosh, D. (2001). Human Immunodeficiency Virus Type 1 Particles Pseudotyped with Envelope Proteins That Fuse at Low pH No Longer Require Nef for Optimal Infectivity. J. Virol. 75: 4014-4018 [Abstract] [Full Text]  
  • Schaeffer, E., Geleziunas, R., Greene, W. C. (2001). Human Immunodeficiency Virus Type 1 Nef Functions at the Level of Virus Entry by Enhancing Cytoplasmic Delivery of Virions. J. Virol. 75: 2993-3000 [Abstract] [Full Text]  
  • Ikuta, K., Suzuki, S., Horikoshi, H., Mukai, T., Luftig, R. B. (2000). Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis. Microbiol. Mol. Biol. Rev. 64: 725-745 [Abstract] [Full Text]  
  • Arthos, J., Rubbert, A., Rabin, R. L., Cicala, C., Machado, E., Wildt, K., Hanbach, M., Steenbeke, T. D., Swofford, R., Farber, J. M., Fauci, A. S. (2000). CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes. J. Virol. 74: 6418-6424 [Abstract] [Full Text]  
  • Accola, M. A., Öhagen, A., Göttlinger, H. G. (2000). Isolation of Human Immunodeficiency Virus Type 1 Cores: Retention of Vpr in the Absence of p6gag. J. Virol. 74: 6198-6202 [Abstract] [Full Text]  
  • Serio, D., Singh, S. P., Cartas, M. A., Weber, I. T., Harrison, R. W., Louis, J. M., Srinivasan, A. (2000). Antiviral agent based on the non-structural protein targeting the maturation process of HIV-1: expression and susceptibility of chimeric Vpr as a substrate for cleavage by HIV-1 protease. Protein Eng Des Sel 13: 431-436 [Abstract] [Full Text]  
  • Akari, H., Arold, S., Fukumori, T., Okazaki, T., Strebel, K., Adachi, A. (2000). Nef-Induced Major Histocompatibility Complex Class I Down-Regulation Is Functionally Dissociated from Its Virion Incorporation, Enhancement of Viral Infectivity, and CD4 Down-Regulation. J. Virol. 74: 2907-2912 [Abstract] [Full Text]  
  • Welker, R., Hohenberg, H., Tessmer, U., Huckhagel, C., Kräusslich, H.-G. (2000). Biochemical and Structural Analysis of Isolated Mature Cores of Human Immunodeficiency Virus Type 1. J. Virol. 74: 1168-1177 [Abstract] [Full Text]  
  • Brown, A., Wang, X., Sawai, E., Cheng-Mayer, C. (1999). Activation of the PAK-Related Kinase by Human Immunodeficiency Virus Type 1 Nef in Primary Human Peripheral Blood Lymphocytes and Macrophages Leads to Phosphorylation of a PIX-p95 Complex. J. Virol. 73: 9899-9907 [Abstract] [Full Text]  
  • Kotov, A., Zhou, J., Flicker, P., Aiken, C. (1999). Association of Nef with the Human Immunodeficiency Virus Type 1 Core. J. Virol. 73: 8824-8830 [Abstract] [Full Text]  
  • Schrager, J. A., Marsh, J. W. (1999). HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. USA 96: 8167-8172 [Abstract] [Full Text]  
  • Carl, S., Iafrate, A. J., Skowronski, J., Stahl-Hennig, C., Kirchhoff, F. (1999). Effect of the Attenuating Deletion and of Sequence Alterations Evolving In Vivo on Simian Immunodeficiency Virus C8-Nef Function. J. Virol. 73: 2790-2797 [Abstract] [Full Text]  
  • Dettenhofer, M., Yu, X.-F. (1999). Highly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions. J. Virol. 73: 1460-1467 [Abstract] [Full Text]  
  • Welker, R., Harris, M., Cardel, B., Krausslich, H.-G. (1998). Virion Incorporation of Human Immunodeficiency Virus Type 1 Nef Is Mediated by a Bipartite Membrane-Targeting Signal: Analysis of Its Role in Enhancement of Viral Infectivity. J. Virol. 72: 8833-8840 [Abstract] [Full Text]  
  • Craig, H. M., Pandori, M. W., Guatelli, J. C. (1998). Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. USA 95: 11229-11234 [Abstract] [Full Text]  
  • Aldrovandi, G. M., Gao, L., Bristol, G., Zack, J. A. (1998). Regions of Human Immunodeficiency Virus Type 1 nef Required for Function In Vivo. J. Virol. 72: 7032-7039 [Abstract] [Full Text]  
  • Hodge, D. R., Dunn, K. J., Pei, G. K., Chakrabarty, M. K., Heidecker, G., Lautenberger, J. A., Samuel, K. P. (1998). Binding of c-Raf1 Kinase to a Conserved Acidic Sequence within the Carboxyl-terminal Region of the HIV-1 Nef Protein. J. Biol. Chem. 273: 15727-15733 [Abstract] [Full Text]  
  • D'Aloja, P., Olivetta, E., Bona, R., Nappi, F., Pedacchia, D., Pugliese, K., Ferrari, G., Verani, P., Federico, M. (1998). gag, vif, and nef Genes Contribute to the Homologous Viral Interference Induced by a Nonproducer Human Immunodeficiency Virus Type 1 (HIV-1) Variant: Identification of Novel HIV-1-Inhibiting Viral Protein Mutants. J. Virol. 72: 4308-4319 [Abstract] [Full Text]  
  • Chen, Y.-L., Trono, D., Camaur, D. (1998). The Proteolytic Cleavage of Human Immunodeficiency Virus Type 1 Nef Does Not Correlate with Its Ability To Stimulate Virion Infectivity. J. Virol. 72: 3178-3184 [Abstract] [Full Text]  
  • Liu, L. X., Margottin, F., Le Gall, S., Schwartz, O., Selig, L., Benarous, R., Benichou, S. (1997). Binding of HIV-1 Nef to a Novel Thioesterase Enzyme Correlates with Nef-mediated CD4 Down-regulation. J. Biol. Chem. 272: 13779-13785 [Abstract] [Full Text]  
  • Coates, K., Cooke, S. J., Mann, D. A., Harris, M. P. G. (1997). Protein Kinase C-mediated Phosphorylation of HIV-I Nef in Human Cell Lines. J. Biol. Chem. 272: 12289-12294 [Abstract] [Full Text]  
  • Serio, D., Rizvi, T. A., Cartas, M., Kalyanaraman, V. S., Weber, I. T., Koprowski, H., Srinivasan, A. (1997). Development of a novel anti-HIV-1 agent from within: Effect of chimeric Vpr-containing protease cleavage site residues on virus replication. Proc. Natl. Acad. Sci. USA 94: 3346-3351 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»